Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LHAA
2226
DELISTED
Lerer Hippeau Acquisition Corp. Class A Common Stock
LHAA
| $8.6M | 0.01% |
883,210
-12,020
| -1% | -$117K |
|
2227
Descartes Systems
DSGX
$6.91B
| $8.59M | 0.01% |
105,712
+91,634
| +651% | +$6.94M |
|
2228
Aptiv
APTV
$9.43B
| $8.59M | 0.01% |
57,679
+30,270
| +110% | +$4.71M |
|
|
AGGRU
2229
DELISTED
Agile Growth Corp Units
AGGRU
| $8.59M | 0.01% |
867,926
+2,209
| +0.3% | +$21.9K |
|
2230
Rackspace Technology
RXT
$861M
| $8.58M | 0.01% |
603,428
-197,511
| -25% | -$3.17M |
|
|
MCHB
2231
Mechanics Bancorp
MCHB
$3.56B
| $8.55M | 0.01% |
207,692
-24,251
| -10% | -$948K |
|
2232
Trinity Industries
TRN
$2.35B
| $8.54M | 0.01% |
314,350
-210,074
| -40% | -$5.8M |
|
2233
Park Hotels & Resorts
PK
$3.16B
| $8.54M | 0.01% |
445,951
+36,853
| +9% | +$696K |
|
2234
Shutterstock
SSTK
$203M
| $8.54M | 0.01% |
75,322
+19,714
| +35% | +$2.13M |
|
2235
Honda
HMC
$40.7B
| $8.53M | 0.01% |
278,101
-30,553
| -10% | -$961K |
|
2236
PUT
Yum! Brands
YUM
$41.1B
| $8.51M | 0.01% |
69,600
| – | – |
|
|
PENG
2237
Penguin Solutions Inc
PENG
$2.69B
| $8.51M | 0.01% |
382,524
+88,180
| +30% | +$2.11M |
|
2238
Elbit Systems
ESLT
$33.7B
| $8.51M | 0.01% |
58,732
+53,588
| +1,042% | +$7.4M |
|
|
GSAQ
2239
DELISTED
Global Synergy Acquisition Corp. Class A Ordinary Shares
GSAQ
| $8.49M | 0.01% |
866,827
+209,084
| +32% | +$2.04M |
|
|
TRTN
2240
DELISTED
Triton International Limited
TRTN
| $8.49M | 0.01% |
163,150
+25,635
| +19% | +$1.33M |
|
|
SPKBU
2241
DELISTED
Silver Spike Acquisition Corp II Units
SPKBU
| $8.49M | 0.01% |
847,724
| – | – |
|
2242
CALL
Aon
AON
$74.2B
| $8.49M | 0.01% |
29,700
-155,700
| -84% | -$41.8M |
|
2243
Century Aluminum
CENX
$4.54B
| $8.48M | 0.01% |
630,846
+382,756
| +154% | +$4.81M |
|
2244
Aurinia Pharmaceuticals
AUPH
$2.19B
| $8.48M | 0.01% |
+383,390
| New | +$6.08M |
|
|
KDNY
2245
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $8.48M | 0.01% |
664,476
+352,915
| +113% | +$4.65M |
|
|
HAAC
2246
DELISTED
Health Assurance Acquisition Corp. Class A Common Stock
HAAC
| $8.47M | 0.01% |
865,857
-628,529
| -42% | -$6.15M |
|
|
ELIQ
2247
DELISTED
Electriq Power Holdings, Inc.
ELIQ
| $8.47M | 0.01% |
859,515
-12,634
| -1% | -$122K |
|
2248
Bally's
BALY
$459M
| $8.46M | 0.01% |
168,627
+122,186
| +263% | +$5.96M |
|
|
CTV
2249
DELISTED
Innovid Corp.
CTV
| $8.45M | 0.01% |
852,308
+357,127
| +72% | +$3.53M |
|
2250
Lufax Holding
LU
$1.1B
| $8.44M | 0.01% |
302,165
-91,368
| -23% | -$3.03M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.